{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:09:51Z","timestamp":1776362991120,"version":"3.51.2"},"reference-count":14,"publisher":"Oxford University Press (OUP)","funder":[{"name":"Natural Science Foundation of Liaoning Province of China","award":["20092055"],"award-info":[{"award-number":["20092055"]}]},{"name":"Scientific Research Fund of Education Department of Liaoning Province","award":["L2012150"],"award-info":[{"award-number":["L2012150"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Chromatogr Sci"],"DOI":"10.1093\/chromsci\/bmw192","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T12:08:32Z","timestamp":1481976512000},"source":"Crossref","is-referenced-by-count":2,"title":["Development and Validation of a Gas Chromatography Method for Quality Control of Residual Solvents in Azilsartan Bulk Drugs"],"prefix":"10.1093","author":[{"given":"Jin","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"key":"2016122417101578000_bmw192v1.1","unstructured":"International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Q3C (R5): Impurities: Guideline for Residual Solvents, Step 4, February, (2011)."},{"key":"2016122417101578000_bmw192v1.2","doi-asserted-by":"publisher","DOI":"10.1039\/an9911601327"},{"key":"2016122417101578000_bmw192v1.3","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022693516409"},{"key":"2016122417101578000_bmw192v1.4","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.3390\/molecules19078707","article-title":"Determination of volatile organic compounds (VOCs) from wrapping films and wrapped PDO Italian cheeses by using HS-SPME and GC\/MS","volume":"19","author":"Sara","year":"2014","journal-title":"Molecules"},{"key":"2016122417101578000_bmw192v1.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-014-6530-0"},{"key":"2016122417101578000_bmw192v1.6","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.176636"},{"key":"2016122417101578000_bmw192v1.7","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/0960-894X(95)00319-O","article-title":"A new class of angiotensin II receptor antagonists with a novel acidic bioisostere","volume":"5","author":"Kohara","year":"1995","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"2016122417101578000_bmw192v1.8","doi-asserted-by":"publisher","DOI":"10.1021\/jm960547h"},{"key":"2016122417101578000_bmw192v1.9","unstructured":"Naka, T. , Inada, Y. ; Heterocyclic compounds, their production and use as angiotensin II antagonists; EP 0520423 A2, (1992)."},{"key":"2016122417101578000_bmw192v1.10","unstructured":"Naka, T. , Inada, Y. ; Heterocyclic compounds and their use as angiotensin antagonists; US 5583141 A, (1996)."},{"key":"2016122417101578000_bmw192v1.11","unstructured":"Kuroita, T. , Sakamoto, H. , Ojima, M. ; Benzimidazole derivative and use thereof; US 20050187269 A1, (2005)."},{"key":"2016122417101578000_bmw192v1.12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/op3002867","article-title":"Improved process for azilsartan medoxomil: a new angiotensin receptor blocker","volume":"17","author":"Stanislav","year":"2013","journal-title":"Organic Process Research & Development"},{"key":"2016122417101578000_bmw192v1.13","unstructured":"International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Q2 (R1): Validation of Analytical Procedures: Methodology, Step 4, November, (2005)."},{"key":"2016122417101578000_bmw192v1.14","unstructured":"United States Pharmacopeia. (2009), USP31\/NF26 \u2013 General chapter < 467 > residual solvents."}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/55\/4\/393\/10981018\/bmw192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T01:37:02Z","timestamp":1503625022000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article-lookup\/doi\/10.1093\/chromsci\/bmw192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,23]]},"references-count":14,"alternative-id":["10.1093\/chromsci\/bmw192"],"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmw192","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,23]]}}}